Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Do Seon Song

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Gut and Liver|April 7, 2026
Liver Failure versus Organ Failure in Acute-on-Chronic Liver Failure: Sequence and ConsequenceYoung Chang, Jae Young Jang, Soung Won Jeong, et al.
Frontiers in Oncology|March 14, 2024
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative studyJi Won Han, Pil Soo Sung, Jae-Sung Yoo, et al.
International Journal of Cancer|March 14, 2020
Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real-life settingsKwon Yong Tak, Hee Chul Nam, Jong Young Choi, et al.
Clinical and Molecular Hepatology|June 22, 2021
KASL clinical practice guidelines: Management of nonalcoholic fatty liver diseaseSeong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2025
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and BevacizumabJaejun Lee, Keungmo Yang, Ji Won Han, et al.
NPJ Digital Medicine|May 21, 2026
Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapyJi Won Han, Jaejun Lee, Keungmo Yang, et al.
Journal of Viral Hepatitis|January 14, 2026
Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral HospitalsHee Yeon Kim, Hae Lim Lee, Heechul Nam, et al.
Liver Cancer|March 19, 2026
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic TreatmentsJaejun Lee, Hyun Yang, Si Hyun Bae, et al.
The Korean Journal of Internal Medicine|August 18, 2022
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney diseaseJi Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, et al.
Gut and Liver|April 11, 2025
Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: A Multicenter Cohort AnalysisJihye Lim, Ji Hoon Kim, Ahlim Lee, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Gut and Liver|April 7, 2026
Liver Failure versus Organ Failure in Acute-on-Chronic Liver Failure: Sequence and ConsequenceYoung Chang, Jae Young Jang, Soung Won Jeong, et al.
Frontiers in Oncology|March 14, 2024
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative studyJi Won Han, Pil Soo Sung, Jae-Sung Yoo, et al.
International Journal of Cancer|March 14, 2020
Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real-life settingsKwon Yong Tak, Hee Chul Nam, Jong Young Choi, et al.
Clinical and Molecular Hepatology|June 22, 2021
KASL clinical practice guidelines: Management of nonalcoholic fatty liver diseaseSeong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2025
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and BevacizumabJaejun Lee, Keungmo Yang, Ji Won Han, et al.
NPJ Digital Medicine|May 21, 2026
Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapyJi Won Han, Jaejun Lee, Keungmo Yang, et al.
Journal of Viral Hepatitis|January 14, 2026
Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral HospitalsHee Yeon Kim, Hae Lim Lee, Heechul Nam, et al.
Liver Cancer|March 19, 2026
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic TreatmentsJaejun Lee, Hyun Yang, Si Hyun Bae, et al.
The Korean Journal of Internal Medicine|August 18, 2022
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney diseaseJi Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, et al.
Gut and Liver|April 11, 2025
Predicting Mortality and Cirrhosis-Related Complications with MELD3.0: A Multicenter Cohort AnalysisJihye Lim, Ji Hoon Kim, Ahlim Lee, et al.
Pageof 10